Nate Duke
About Nate Duke
Nate Duke is a Clinical Research Associate with over 13 years of experience at Celerion and has been the owner of Control Investments LLC since 2016.
Work at Celerion
Nate Duke has been employed at Celerion since 2011, serving as a Clinical Research Associate. His role involves overseeing clinical trials and ensuring compliance with regulatory standards. He contributes to the management of study protocols and data collection processes, which are essential for the successful execution of clinical research. Celerion is known for its focus on providing clinical research services, and Duke's long tenure reflects his commitment to the organization and the field of clinical research.
Work at Control Investments LLC
Since 2016, Nate Duke has been the owner of Control Investments LLC. In this capacity, he manages the operations of the company, which is based in the United States. His experience as a Clinical Research Associate likely informs his business practices and decision-making within the company. Control Investments LLC focuses on various investment opportunities, and Duke's leadership plays a crucial role in its strategic direction.
Education and Expertise
Nate Duke possesses expertise in clinical research, with a focus on the responsibilities associated with being a Clinical Research Associate. His extensive experience in the field, spanning over a decade at Celerion, indicates a strong foundation in clinical trial management, regulatory compliance, and data analysis. This expertise is essential for navigating the complexities of clinical research and ensuring the integrity of study outcomes.
Background
Nate Duke has a professional background that includes significant experience in clinical research and business ownership. His career began in 2011 at Celerion, where he has developed skills pertinent to clinical trials and research methodologies. In addition to his role at Celerion, he has been involved in managing Control Investments LLC since 2016, demonstrating a diverse professional trajectory that combines clinical research with business management.